As of 2026-01-13, the Relative Valuation of Edwards Lifesciences Corp (EW) is 91.05 USD. This relative valuation is based on P/E multiples. With the latest stock price at 85.13 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is 6.9%.
The range of the Relative Valuation is 84.84 - 125.90 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.4x - 43.4x | 37.8x |
| Forward P/E multiples | 31.7x - 47.0x | 34.7x |
| Fair Price | 84.84 - 125.90 | 91.05 |
| Upside | -0.3% - 47.9% | 6.9% |
| Date | P/E |
| 2026-01-12 | 35.22 |
| 2026-01-09 | 36.11 |
| 2026-01-08 | 35.88 |
| 2026-01-07 | 35.99 |
| 2026-01-06 | 36.42 |
| 2026-01-05 | 35.71 |
| 2026-01-02 | 36.20 |
| 2025-12-31 | 36.17 |
| 2025-12-30 | 36.57 |
| 2025-12-29 | 36.88 |
| 2025-12-26 | 36.84 |
| 2025-12-24 | 36.61 |
| 2025-12-23 | 36.58 |
| 2025-12-22 | 36.71 |
| 2025-12-19 | 36.34 |
| 2025-12-18 | 35.97 |
| 2025-12-17 | 35.99 |
| 2025-12-16 | 36.20 |
| 2025-12-15 | 35.37 |
| 2025-12-12 | 35.24 |
| 2025-12-11 | 35.74 |
| 2025-12-10 | 35.60 |
| 2025-12-09 | 35.33 |
| 2025-12-08 | 35.77 |
| 2025-12-05 | 36.56 |
| 2025-12-04 | 36.39 |
| 2025-12-03 | 35.63 |
| 2025-12-02 | 35.94 |
| 2025-12-01 | 36.17 |
| 2025-11-28 | 36.77 |
| 2025-11-26 | 36.80 |
| 2025-11-25 | 36.83 |
| 2025-11-24 | 35.94 |
| 2025-11-21 | 36.11 |
| 2025-11-20 | 35.67 |
| 2025-11-19 | 36.49 |
| 2025-11-18 | 35.65 |
| 2025-11-17 | 35.95 |
| 2025-11-14 | 36.61 |
| 2025-11-13 | 36.53 |
| 2025-11-12 | 36.31 |
| 2025-11-11 | 36.13 |
| 2025-11-10 | 35.67 |
| 2025-11-07 | 35.38 |
| 2025-11-06 | 34.97 |
| 2025-11-05 | 35.14 |
| 2025-11-04 | 35.70 |
| 2025-11-03 | 35.24 |
| 2025-10-31 | 34.98 |
| 2025-10-30 | 35.41 |